Patents by Inventor Esko Kankuri

Esko Kankuri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • APPARATUS AND METHOD FOR MECHANICALLY DISINTEGRATING TISSUE INTO MICROGRAFTS, AND FEEDER PIECE USED IN CONNECTION WITH THE DISINTEGRATION OF TISSUE
    Publication number: 20230301680
    Abstract: For improving the quality of grated tissue, a method is presented for mechanically disintegrating tissue (2) into micro-grafts, in which method a blade part (3), which has a planar grater surface (3.1), and the tissue placed in a tissue holder are made to move relative to each other, and where the tissue is guided against the grater surface (3.1), characterised in that the tissue is guided against the grater surface (3.1) together with the tissue feeder piece so that the feeder piece (12) is disintegrated together with the tissue (2). The application also includes independent claims concerning an apparatus for mechanically disintegrating tissue into micrografts, and a feeder piece.
    Type: Application
    Filed: October 14, 2021
    Publication date: September 28, 2023
    Inventors: Kai KRONSTRÖM, Aleksi KUUVA, Esko KANKURI
  • Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring
    Patent number: 9833540
    Abstract: The present invention relates to nanofibrillar polysaccharide hydrogels for use in the prevention and control of scarring and contraction in connection with wound healing or tissue repair.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: December 5, 2017
    Assignee: UPM-KYMMENE CORPORATION
    Inventors: Antti Laukkanen, Esko Kankuri, Kristo Nuutila
  • NANOFIBRILLAR POLYSACCHARIDE FOR USE IN THE CONTROL AND PREVENTION OF CONTRACTION AND SCARRING
    Publication number: 20150367024
    Abstract: The present invention relates to nanofibrillar polysaccharide hydrogels for use in the prevention and control of scarring and contraction in connection with wound healing or tissue repair.
    Type: Application
    Filed: February 21, 2014
    Publication date: December 24, 2015
    Inventors: Antti Laukkanen, Esko Kankuri, Kristo Nuutila
  • ACTIVATED FIBROBLASTS FOR TREATING TISSUE AND/OR ORGAN DAMAGE
    Publication number: 20110123572
    Abstract: The invention provides activated fibroblasts for the treatment of tissue and/or organ damage in a patient. Fibroblasts are activated by culturing the cells under conditions that induce the cells to adhere to each other and simultaneously to secrete growth factors, especially hepatocyte growth factor, HGF. The invention also provides a pharmaceutical composition based on the medium in which the activated fibroblasts are cultured. The invention further provides methods for transplantation.
    Type: Application
    Filed: August 16, 2007
    Publication date: May 26, 2011
    Applicant: Licentia Ltd.
    Inventors: Jozef Bizik, Ari Harjula, Esko Kankuri, Antti Vaheri